Trials & R&D · first seen yesterday, updated yesterday
Crispr on demand? Mutation-agnostic gene therapy trial nears clinic
Crispr genome editing could in theory be programmed to address any gene mutation, providing cures on demand for life-threatening inherited rare diseases in newborns. The challenge is to develop a platform that can be applied at scale and wi…
Summary from BioWorld Articles.
Coverage 1 article · 1 outlet
-
BioWorld ArticlesCrispr on demand? Mutation-agnostic gene therapy trial nears clinic